Sodium Bicarbonate Administration in Malignant Hyperthermia with Metabolic Acidosis
Administer sodium bicarbonate with a low threshold in malignant hyperthermia patients with metabolic acidosis, as low pH values are associated with poor outcomes, while prioritizing hyperventilation as the primary acidosis management strategy. 1
Primary Management Hierarchy
Hyperventilation is the primary treatment for acidosis in malignant hyperthermia, but sodium bicarbonate should be administered early given the association between low pH and mortality. 1 The Association of Anaesthetists explicitly recommends a low threshold for bicarbonate use in this specific context, distinguishing MH from other causes of metabolic acidosis where bicarbonate remains controversial. 1
Specific Indications for Sodium Bicarbonate in MH
Sodium bicarbonate serves three critical functions in malignant hyperthermia:
- Correction of severe metabolic acidosis when pH remains low despite adequate hyperventilation 1
- Treatment of life-threatening hyperkalemia by facilitating potassium reuptake into cells 1, 2
- Urinary alkalinization to prevent myoglobin precipitation and reduce acute kidney injury risk from rhabdomyolysis 1, 3
Dosing Protocol
For cardiac arrest or severe acidosis in MH, administer one to two 50 mL vials (44.6 to 100 mEq) initially, continuing at 50 mL every 5-10 minutes as indicated by arterial blood gas monitoring. 4 In less urgent metabolic acidosis, use 2-5 mEq/kg over 4-8 hours, with dosing guided by serial blood gas analysis. 4
For hyperkalemia management specifically, combine sodium bicarbonate with glucose 50 ml of 50% solution plus insulin 10 units. 1
Critical Monitoring Requirements
- Arterial blood gas analysis should guide all bicarbonate administration decisions 1
- Avoid full correction of acidosis within the first 24 hours, as delayed ventilatory readjustment can produce unrecognized alkalosis 4
- Target total CO2 content of approximately 20 mEq/L at the end of the first day, which typically correlates with normal blood pH 4
- Monitor for hypernatremia, as bicarbonate solutions are hypertonic and may produce undesirable sodium elevation 4
Important Caveats Specific to Malignant Hyperthermia
Do NOT use intravenous calcium except in extremis for hyperkalemia in MH, as extracellular calcium influx contributes to myoplasmic calcium overload. 1 This represents a critical departure from standard hyperkalemia protocols.
Avoid potassium-containing fluids (Ringer's lactate, Hartmann's solution) as potassium levels can increase markedly after reperfusion even with intact renal function. 2
Clinical Context and Evidence Strength
While general critical care literature questions routine bicarbonate use in metabolic acidosis 5, and rhabdomyolysis guidelines recommend against urinary alkalinization 2, the 2021 Association of Anaesthetists MH guidelines explicitly recommend liberal bicarbonate use given the unique pathophysiology and poor outcomes associated with low pH in MH specifically. 1 This represents high-quality, disease-specific guidance that supersedes general acidosis management principles.
Approximately 53.9% of MH patients receive bicarbonate therapy in clinical practice, and metabolic acidosis occurs in only 26% of MH cases despite respiratory acidosis occurring in 78.6%. 6 This suggests bicarbonate is appropriately reserved for specific indications rather than used universally.
Urinary Alkalinization for Myoglobinuria
Administer sodium bicarbonate to alkalinize urine in MH patients with myoglobinuria, targeting urine output >2 ml/kg/hour. 1, 3 While controversy exists regarding alkalinization benefit in preventing acute kidney injury, myoglobin is less likely to precipitate in alkaline urine, and the Association of Anaesthetists found no convincing evidence of harm in this situation. 1